Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Exagen Announces Appointment of John Aballi as CEO

    Oct 18, 2022, 10:39 AM by
    Exagen Inc. (Nasdaq: XGN), announced today that the company has appointed John Aballi as CEO and President. Longtime CEO and President Ron Rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.
    Full story
  • Illumina Unveils New Fleet Of Sequencing Instruments

    Oct 18, 2022, 01:00 AM by User Not Found
    Bio-IT World | The recent Illumina Genomics Forum occasioned the launch of several game-changing products, including the first FDA-regulated and CE-marked in vitro diagnostic high-throughput sequencer (NovaSeq 6000 Dx) and the company’s most powerful sequencer to date (NovaSeq X series) that can run 20,000 whole human genomes a year on a single instrument.
    Full story
  • With More Oncology Data at Our Fingertips, Interpretation Tools Are Key

    Oct 14, 2022, 01:00 AM by User Not Found
    Bio-IT World | Oncology has been a shining example of the promise of precision medicine, and the tremendous gains to be made in human health when patients can be prescribed the right drug at the right time. But oncology has also shown the challenge of precision medicine: data interpretation. With each new source of data, the difficulty of making sense of the aggregated information only increases.
    Full story
  • InsightRX Offers Precision Dosing Support for New Drug Categories

    Oct 13, 2022, 09:45 AM by
    InsightRX Offers Precision Dosing Support for New Drug Categories. New modules provide inpatient and outpatient dosing guidance for azole antifungals, solid organ transplant drugs, and inflammatory bowel disease biologics
    Full story
  • Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer Primary tabs

    Oct 13, 2022, 09:38 AM by
    Maternova, Inc. announces the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.
    Full story
  • Samsung Biologics unlocks additional capacity for production at its newest Plant 4

    Oct 13, 2022, 09:23 AM by
    Full story
  • Interactive Microbial Atlas Outlines Associations Between the Gut Microbiome and Plasma Metabolites

    Oct 13, 2022, 01:00 AM by User Not Found
    Bio-IT World | A team of Swedish researchers from Uppsala and Lund Universities created the first large-scale microbial atlas, linking gut microbiota to specific metabolites and their potential health impact on humans.
    Full story
  • Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

    Oct 12, 2022, 09:32 AM by
    Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.
    Full story
  • Sharp Adds New Talent with Clinical Leadership Appointments

    Oct 12, 2022, 09:32 AM by
    Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.
    Full story
  • High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

    Oct 12, 2022, 09:31 AM by
    BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.
    Full story
  • New Cotiviti Solution Enables Health Plans to Predict and Improve Medicare Advantage Star Ratings

    Oct 12, 2022, 09:31 AM by
    Amid industry-wide ratings decline, Star Intelligence helps organizations track, predict, and model CMS Star Ratings
    Full story
  • ChargePoint Technology collaborates with STERIS to deliver sterile solution success for Evonik

    Oct 11, 2022, 11:13 AM by
    Full story
  • Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow

    Oct 11, 2022, 11:12 AM by
    Watson-Marlow Fluid Technology Solutions announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with other WMFTS products, it reinforces the company’s position as a provider of total-solution packages for customers utilising fluid path processes.
    Full story
  • CTL Amedica gets FDA clearance for MONDRIAN™ ALIF Cage System with Supplementary Fixation Plate

    Oct 11, 2022, 11:12 AM by
    CTL Amedica Corporation has received official 510k clearance from the U.S. FDA to market its MONDRIAN Anterior Lumbar Interbody Fusion (ALIF) Cage System with Supplementary Fixation Plate. It features CTL Amedica’s proprietary TiCro surface technology, which significantly increases endplate contact surface area and enhances interlocking properties.
    Full story
  • BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

    Oct 11, 2022, 11:10 AM by
    BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.
    Full story
  • BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

    Oct 11, 2022, 11:09 AM by
    The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.
    Full story
  • BOC Sciences Honored To Assist in the Antibody Research With High-Quality Chemicals

    Oct 11, 2022, 11:09 AM by
    BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.
    Full story
  • BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!

    Oct 11, 2022, 11:08 AM by
    BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.
    Full story
  • AxisPharm's research in the field of bioanalysis and PK drive

    Oct 11, 2022, 11:08 AM by
    AxisPharm bioanalytical chemistry department specializes in developing and validating robust bioanalytical methods for PK/TK sample analysis of small molecules, proteins, peptides, and metabolites using LCMS/MS (HPLC, UPLC, on-line SPE), HPLC/UV, and HPLC/FL.
    Full story
  • MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

    Oct 11, 2022, 11:07 AM by
    Full story
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy